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Complete colorblindness (achromatopsia) is caused by
autosomal recessively inherited mutations in the retinal
phototransduction pathway, predominantly in the
CNGA3- and CNGB3-subunit of the cyclic nucleotide-
gated (CNG) channels in cone photoreceptors. CNGA3,
which is mutated in about 25% of the achromatopsia
patients, mainly harbors missense mutations which fre-
quently impair the folding and/or trafficking of the
mutant CNGA3-channels [1].
Pharmacological chaperones stabilizing the folding of
the mutant protein may be used to overcome this fold-
ing-/trafficking-deficiency. More than 50 compounds were
evaluated in their ability to restore signal transduction
using a calcium imaging-based bioassay utilizing the
CNGA3-mutant E228K [2]. With this data we created sev-
eral pharmacophore models using Schrödinger Phase [3],
which describe the chemical features of potential pharma-
cological chaperones targeting achromatopsia.
We used several approaches leading to different phar-
macophore hypotheses:
a) Training with the complete set of experimental data
(see Figure 1)
b) Training with only dihydropyridines since this
group showed the highest experimental activity, and
c) Training with a data set excluding dihydropyridines.
Our in-house database TueScreen, which includes
ZINC12 [4], was screened to identify potentially active
compounds. As a result, several potential molecule classes
could be found that may be useful as pharmacological
chaperones to improve folding/trafficking of mutant
CNG-channels. We will experimentally validate these pre-
dictions in a calcium imaging-based bioassay.
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Figure 1 Pharmacophore depicting potential features of CNG
channel-chaperones.
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